Biomatter Raises $18M Series A to Expand AI Enzyme Design and Testing
Biomatter announced on November 12, 2026, that it had closed an oversubscribed $18 million Series A led by Astanor, with participation from existing investors UVC Partners, Inventure and Metaplanet. The company will
Read more


